BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Iperboreal Pharma readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Iperboreal Pharma's drugs run\, f
 rom ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03994874-616@assetmemo.bio
DTSTAMP:20261121T005447Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:PolyCore: Phase 1/2 readout est. (NCT03994874)
DESCRIPTION:PolyCore\, phase 1/2\, Heart Failure.\nStudy: Peritoneal Ultraf
 iltration in Cardio Renal Syndrome.\nEstimated primary completion: Decembe
 r 2026. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/polycore#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT03994874
URL:https://assetmemo.bio/drug/polycore#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
